The Epclusa cost varies significantly across different countries due to several factors, including local healthcare regulations, market demand, and the presence of generic alternatives. In high-income countries like the United States, the price of Epclusa can be quite high, often reaching tens of thousands of dollars for a full treatment course. However, in lower-income countries, prices are often lower due to generic versions being available through licensing agreements with pharmaceutical companies. Other factors influencing its pricing include patent protections, government subsidies, insurance coverage, and the overall healthcare system in each country. This wide variation in cost makes access to Epclusa more challenging in certain regions, while more affordable in others.